HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M R Daha Selected Research

Arthritis (Polyarthritis)

8/2006The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M R Daha Research Topics

Disease

10Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2008 - 01/2001
7Inflammation (Inflammations)
02/2015 - 01/2000
4IGA Glomerulonephritis (IGA Nephropathy)
05/2008 - 07/2000
3Hematuria
04/2006 - 01/2000
3Autoimmune Diseases (Autoimmune Disease)
01/2004 - 01/2001
3Lupus Nephritis
01/2004 - 11/2003
3Nephritis
01/2004 - 01/2000
2Disease Progression
02/2015 - 08/2006
2Reperfusion Injury
10/2014 - 04/2012
2Rheumatoid Arthritis
07/2009 - 01/2001
2Infections
01/2009 - 08/2001
2Bacterial Infections (Bacterial Infection)
01/2009 - 05/2001
2Hereditary Complement Deficiency Diseases
01/2005 - 08/2001
2Meningococcal Infections
05/2001 - 05/2000
2Proteinuria
07/2000 - 01/2000
1Fibrosis (Cirrhosis)
02/2015
1Ischemia
10/2014
1Brain Death (Brain Dead)
04/2013
1Albuminuria
07/2009
1Stroke (Strokes)
06/2009
1Virus Diseases (Viral Diseases)
01/2009
1Sepsis (Septicemia)
01/2009
1Hereditary Angioedemas
07/2008
1Atherosclerosis
12/2006
1Arthritis (Polyarthritis)
08/2006
1Reinfection
01/2005
1Immune Complex Diseases (Immune Complex Disease)
12/2001
1Glomerulonephritis
03/2001
1Hemorrhage
02/2001
1Systemic Scleroderma (Systemic Sclerosis)
01/2001
1Undifferentiated Connective Tissue Diseases
01/2001
1Dermatomyositis (Dermatopolymyositis)
01/2001
1Aneurysm (Aneurysms)
07/2000
1Neoplasms (Cancer)
03/2000
1Microaneurysm
01/2000

Drug/Important Bio-Agent (IBA)

21Complement System Proteins (Complement)IBA
02/2015 - 01/2000
8AntibodiesIBA
05/2008 - 07/2000
7AutoantibodiesIBA
01/2005 - 08/2001
4Immunoglobulin A (IgA)IBA
05/2008 - 07/2000
3LectinsIBA
02/2015 - 08/2006
3Complement Membrane Attack Complex (Membrane Attack Complex)IBA
10/2014 - 03/2000
3Proteins (Proteins, Gene)FDA Link
04/2013 - 03/2000
3Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
04/2012 - 11/2003
3Immunoglobulin G (IgG)IBA
12/2003 - 07/2000
2Monoclonal AntibodiesIBA
10/2014 - 07/2000
2Secretory Immunoglobulin A (SIgA)IBA
05/2008 - 04/2006
2polymeric IgAIBA
05/2008 - 07/2000
2ProperdinIBA
07/2000 - 05/2000
1Protein Kinases (Protein Kinase)IBA
02/2015
1Biomarkers (Surrogate Marker)IBA
02/2015
1Protein Glutamine gamma Glutamyltransferase 2IBA
02/2015
1Phosphotransferases (Kinase)IBA
02/2015
1Indicators and Reagents (Reagents)IBA
07/2009
1acetyl 4-aminosalicylic acidIBA
07/2009
1Anti-Citrullinated Protein AntibodiesIBA
07/2009
1ProcalcitoninIBA
01/2009
1Complement Receptors (Complement Receptor)IBA
12/2006
1ApolipoproteinsIBA
12/2006
1Glycoproteins (Glycoprotein)IBA
08/2006
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
08/2006
1ThrombomodulinIBA
08/2006
1LigandsIBA
08/2006
1ThrombinFDA Link
08/2006
1Nuclear Proteins (Protein, Nuclear)IBA
11/2003
1DNA (Deoxyribonucleic Acid)IBA
11/2003
1FibrinIBA
02/2001
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2001
1Fc gamma receptor IIAIBA
05/2000
1anti-Thy antibodyIBA
01/2000
1Phosphates (Orthophosphate)IBA
01/2000

Therapy/Procedure

1Transplantation
04/2013
1Kidney Transplantation
04/2012
1Injections
07/2000